Treatment with relugolix and concomitant therapies for prostate cancer showed similar safety and efficacy to relugolix alone in a recent study. Treatment with relugolix and concomitant therapies for ...
Please provide your email address to receive an email when new articles are posted on . Researchers identified 645 patients with IPF (mean age, 69 years; 76% men) who received nintedanib (Ofev, ...
Please provide your email address to receive an email when new articles are posted on . Concomitant medication burden is associated with antifibrotic medication intolerance among patients with ...
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer ...
The prognostic significance of concomitant statin use in cancer treatment with immune checkpoint inhibitors (ICIs) remains a subject of ongoing investigation. This study aims to clarify the prognostic ...
The phase 3b TOGETHER-PsA trial evaluated the safety and efficacy of concomitant ixekizumab and tirzepatide in adults with active psoriatic arthritis and obesity.
To highlight the importance of actively looking for concomitant cCMV as a routine evaluation of patients presenting with cholestasis and receiving a diagnosis of an inherited liver disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results